These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27008882)

  • 21. Monitoring artemisinin resistance in Plasmodium falciparum: comparison of parasite clearance time by microscopy and real-time PCR and evaluation of mutations in Pfatpase6 gene in Odisha state of India.
    Gupta R; Mishra N; Kumar A; Rana R; Srivastava B; Tyagi PK; Anvikar AR; Valecha N
    Parasitol Res; 2015 Sep; 114(9):3487-96. PubMed ID: 26113507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests.
    Rason MA; Ariey F; Rafidimanantsoa L; Andrianantenaina BH; Sahondra Harisoa JL; Randrianarivelojosia M
    Parasite; 2002 Sep; 9(3):247-53. PubMed ID: 12375368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda.
    Zeile I; Gahutu JB; Shyirambere C; Steininger C; Musemakweri A; Sebahungu F; Karema C; Harms G; Eggelte TA; Mockenhaupt FP
    Acta Trop; 2012 Jan; 121(1):50-4. PubMed ID: 21996622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013.
    Heuchert A; Abduselam N; Zeynudin A; Eshetu T; Löscher T; Wieser A; Pritsch M; Berens-Riha N
    Malar J; 2015 May; 14():208. PubMed ID: 25986047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of copy number variation and single nucleotide polymorphisms in genes involved in drug resistance and other phenotypic traits in P. falciparum clinical isolates collected from Uganda.
    Kiwuwa MS; Byarugaba J; Wahlgren M; Kironde F
    Acta Trop; 2013 Mar; 125(3):269-75. PubMed ID: 23220229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya.
    Lucchi NW; Okoth SA; Komino F; Onyona P; Goldman IF; Ljolje D; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3995-4002. PubMed ID: 25896703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotyping of chloroquine resistant Plasmodium falciparum in wild caught Anopheles minimus mosquitoes in a malaria endemic area of Assam, India.
    Sarma DK; Mohapatra PK; Bhattacharyya DR; Mahanta J; Prakash A
    Trop Biomed; 2014 Sep; 31(3):557-61. PubMed ID: 25382483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
    Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
    Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania.
    Kavishe RA; Kaaya RD; Nag S; Krogsgaard C; Notland JG; Kavishe AA; Ishengoma D; Roper C; Alifrangis M
    Malar J; 2016 Jun; 15():335. PubMed ID: 27339129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India.
    Ahmed A; Lumb V; Das MK; Dev V; Wajihullah ; Sharma YD
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3934-8. PubMed ID: 16982787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deployment and utilization of next-generation sequencing of Plasmodium falciparum to guide anti-malarial drug policy decisions in sub-Saharan Africa: opportunities and challenges.
    Ishengoma DS; Saidi Q; Sibley CH; Roper C; Alifrangis M
    Malar J; 2019 Sep; 18(1):267. PubMed ID: 31477109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
    Lumb V; Das MK; Mittra P; Ahmed A; Kumar M; Kaur P; Dash AP; Singh SS; Sharma YD
    J Infect Dis; 2009 Apr; 199(7):1064-73. PubMed ID: 19220141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a TaqMan Allelic Discrimination assay for detection of single nucleotides polymorphisms associated with anti-malarial drug resistance.
    Kamau E; Alemayehu S; Feghali KC; Tolbert LS; Ogutu B; Ockenhouse CF
    Malar J; 2012 Jan; 11():23. PubMed ID: 22264294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in malaria parasite drug resistance in an endemic population over a 25-year period with resulting genomic evidence of selection.
    Nwakanma DC; Duffy CW; Amambua-Ngwa A; Oriero EC; Bojang KA; Pinder M; Drakeley CJ; Sutherland CJ; Milligan PJ; Macinnis B; Kwiatkowski DP; Clark TG; Greenwood BM; Conway DJ
    J Infect Dis; 2014 Apr; 209(7):1126-35. PubMed ID: 24265439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KASP: a genotyping method to rapid identification of resistance in Plasmodium falciparum.
    Alvarez-Fernandez A; Bernal MJ; Fradejas I; Martin Ramírez A; Md Yusuf NA; Lanza M; Hisam S; Pérez de Ayala A; Rubio JM
    Malar J; 2021 Jan; 20(1):16. PubMed ID: 33407529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs.
    Gruenberg M; Lerch A; Beck HP; Felger I
    Sci Rep; 2019 Nov; 9(1):17790. PubMed ID: 31780741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistance and vaccine target surveillance of Plasmodium falciparum using nanopore sequencing in Ghana.
    Girgis ST; Adika E; Nenyewodey FE; Senoo Jnr DK; Ngoi JM; Bandoh K; Lorenz O; van de Steeg G; Harrott AJR; Nsoh S; Judge K; Pearson RD; Almagro-Garcia J; Saiid S; Atampah S; Amoako EK; Morang'a CM; Asoala V; Adjei ES; Burden W; Roberts-Sengier W; Drury E; Pierce ML; Gonçalves S; Awandare GA; Kwiatkowski DP; Amenga-Etego LN; Hamilton WL
    Nat Microbiol; 2023 Dec; 8(12):2365-2377. PubMed ID: 37996707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiating Plasmodium falciparum alleles by transforming Cartesian X,Y data to polar coordinates.
    DaRe JT; Kouri DP; Zimmerman PA; Thomas PJ
    BMC Genet; 2010 Jun; 11():57. PubMed ID: 20587031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.